The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Cadrenal Therapeutics(NASDAQ:CVKD)

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fib...
Website: https://www.cadrenal.com/
Founded: 2022
IPO Price: $5 (Jan 20, 2023)
Full Time Employees: 1
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Cadrenal Therapeutics Days Payable Outstanding ttm (DPO)
Cadrenal Therapeutics Op Cashflow Per Share ttm
Cadrenal Therapeutics Free Cashflow Per Share ttm
Cadrenal Therapeutics Cash Per Share ttm
Cadrenal Therapeutics (GAAP) P/E ratio ttm
Cadrenal Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.
